v3.26.3
Share-based Compensation (Tables)
 9 Months Ended
Sep. 30, 2026
Share-Based Payment Arrangement [Abstract]  
Schedule of Share-based Compensation
The following table presents total share-based compensation expense within each functional line item on the condensed consolidated statements of operations for the three and nine months ended September 30, 2026 and 2025 (in thousands):
Three Months Ended
September 30,		Nine Months Ended
September 30,
  2026202520262025
Cost of revenues$209 $93 $671 $200 
Research and development232 258 679 792 
Sales and marketing452 200 1,650 489 
General and administrative1,399 1,299 4,645 3,624 
      Total$2,292 $1,850 $7,645 $5,105 
Schedule of Stock Option Activity
The following table summarizes the Company’s stock option activity for the nine months ended September 30, 2026:
Outstanding — December 31, 20251,517,039 
Granted— 
Exercised(38,672)
Canceled(83,743)
Outstanding — September 30, 20261,394,624 
Exercisable — September 30, 2026567,675 
Schedule of Stock Options, Valuation Assumptions The following table details the key assumptions utilized in the Monte Carlo simulation model used to calculate the grant-date fair value of the awards:
Valuation date (January 6, 2025) stock price$11.23 
Simulation term (years)10
Risk-free interest rate4.57 %
Volatility84.00 %
Expected dividend yield— %
The following table details the key assumptions utilized in the Monte Carlo simulation model used to calculate the grant-date fair value of the Market-based CEO RSUs:
Valuation date (January 6, 2025) stock price$11.23 
Simulation term (years)3
Risk-free interest rate4.25 %
Volatility105.63 %
Expected dividend yield— %
Correlation coefficient0.3741
Schedule of Restricted Stock Unit Activity
The following table summarizes the Company’s RSU activity for the nine months ended September 30, 2026:
Non-vested — December 31, 20251,846,156 
Granted383,826 
Vested(400,331)
Forfeited(234,370)
Non-vested — September 30, 20261,595,281